In 2016 Matteo Forloni et al. [52] demonstrated that EGFR triggered the silencing of multiple tumour suppressors in lung adenocarcinoma via C/EBPα transcription factor by inhibiting TET1 expression. The gene discussed is EGFR; the disease is neoplasm.